CRYOPORT, INC. Debt Issuance Costs, Gross
CRYOPORT, INC. (CYRX) had Debt Issuance Costs, Gross of $4.10 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Debt
us-gaap:DeferredFinanceCostsGross · last filed 2021-11-04
- 2021-09-30: Debt Issuance Costs, Gross $4.10M.
- 2021-06-30: Debt Issuance Costs, Gross $4.10M.
- 2021-03-31: Debt Issuance Costs, Gross $4.10M.
- 2020-12-31: Debt Issuance Costs, Gross $4.10M.
| Period end | Debt Issuance Costs, Gross |
|---|---|
| 2021-09-30 | $4.10M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.10M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $4.10M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.10M 10-K · filed 2021-03-01 |
| 2020-09-30 | $4.10M 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |